Cargando…
Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease
BACKGROUND: Despite accumulating epidemiological studies support that diabetes increases the risk of Alzheimer’s disease (AD), the causal associations between diabetes and AD remain inconclusive. The present study aimed to explore: i) whether diabetes is causally related to the increased risk of AD;...
Autores principales: | Meng, Lei, Wang, Zhe, Ji, Hong-Fang, Shen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908591/ https://www.ncbi.nlm.nih.gov/pubmed/35272707 http://dx.doi.org/10.1186/s13578-022-00768-9 |
Ejemplares similares
-
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022) -
Antidiabetic therapies and Alzheimer disease
por: Bendlin, Barbara B
Publicado: (2019) -
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017) -
Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study
por: Tang, Bowen, et al.
Publicado: (2022) -
Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease
por: Ji, Hong-Fang, et al.
Publicado: (2012)